↑↓ navigate open esc close
Portugal BASE contract award · ocds-ted-370892-2026

Portugal – Pharmaceutical products – Dostarlimab 50 mg/ml sol. Inj. Frs. 10 ml IV

Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E. awarded €100 to GLAXOSMITHKLINE - PRODUTOS FARMACÊUTICOS, LDA for Construction & Public Works in June 2026 — one of 76 awards this buyer has made, below its typical award size.

01 Jun 2026
Award date
€100
Contract value
76 Awards
€9.9M Avg award
Below vs typical
3 Awards
2 Buyers
€100 Total won

Contract description

Portugal – Pharmaceutical products – Dostarlimab 50 mg/ml sol. Inj. Frs. 10 ml IV

Premium

Related awards · Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E.

76 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

32 more awards from this buyer · full history & CSV export

Premium

Other wins · GLAXOSMITHKLINE - PRODUTOS FARMACÊUTICOS, LDA

3 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for Instituto Português de Oncologia do Porto Francisco Gentil, E.P.E. and GLAXOSMITHKLINE - PRODUTOS FARMACÊUTICOS, LDA — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up